There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:C07K16/32
Subcategories
This category has the following 22 subcategories, out of 22 total.
A
C
D
F
H
I
J
L
M
O
P
T
U
X
Y
Pages in category "C07K16/32"
The following 25 pages are in this category, out of 25 total.
1
- 18359569. LDL RECEPTOR-DIRECTED BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18517327. BISPECIFIC ANTIGEN-BINDING MOLECULES AND METHODS OF USE simplified abstract (Genentech, Inc.)
- 18552141. SYNTHETIC INTERMEMBRANE PROTEOLYSIS RECEPTORS FOR CUSTOM ANTIGEN-INDUCED TRANSCRIPTIONAL REGULATION simplified abstract (The Regents of the University of California)
- 18558882. DOUBLE SIDED CHIMERIC ANTIGEN RECEPTOR (CAR) ENGINEERED CELL MEMBRANE BASED DRUG DELIVERY SYSTEMS simplified abstract (BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM)
- 18559333. METHODS AND COMPOSITIONS THEREOF FOR SITE-SPECIFIC LABELING OF HUMAN IgG BY PROXIMITY-BASED SORTASE-MEDIATED LIGATION simplified abstract (The Trustees of the University of Pennsylvania)
- 18568218. ANTIBODIES THAT STIMULATE NK CELL-MEDIATED CYTOTOXICITY simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18659241. COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR simplified abstract (GENENTECH, INC.)
- 18835795. PHARMACEUTICAL FORMULATION FOR SUBCUTANEOUS ADMINISTRATION OF PROTEINS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE)
- 18914687. PERTUZUMAB VARIANTS AND EVALUATION THEREOF (Genentech, Inc.)
- 18956269. METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES (Genentech, Inc.)
- 18984106. COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR (GENENTECH, INC.)
- 18991315. Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof (GENENTECH, INC.)